Menu
Global
简体中文
繁体中文
English
Home
About Us
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
Oncology
Digestive
NASH
Investor
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
Contact Us
Address
Contact Information
Adverse drug reaction report
Join XZenith
Our Culture
Careers
Benefit
Talent Development
Employee style
Investor relations
Board of directors
Board of Directors
Ms. Xu Yanjun
Chairman and Executive Director
Dr. Shi Yingkong
Executive Director
Ms. Li Huiying
Non-executive director
Mr. Wei Lifeng
Non-executive director
Ms. Chen Yanling
Non-executive director
Ms. Yue Xin
Employee Representative Director
Mr. Liu Shuo
Independent Non Executive Director
Ms. Wang Yu
Independent Non Executive Director
Mr. Fan Zhichao
Independent Non Executive Director
articles of incorporation
Articles of Association
Procedure for shareholder nominated candidates to run for director
Articles of Association
Terms of Reference and Rules of Procedure of the Audit Committee of the Board
Terms of Reference and Rules of Procedure of the Remuneration and Appraisal Committee of the Board
Terms of Reference and Rules of Procedure of the Nomination Committee of the Board
<
1
>
Home
About Us
+
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
+
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
+
Oncology
Digestive
NASH
Investor
+
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
+
Contact Us
+
Address
Contact Information
Adverse drug reaction report
Join XZenith
+
Our Culture
Careers
Benefit
Talent Development
Employee style